F. R. Silveira

Association between −250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL‐C levels in a Southern Brazilian population

M. Hutz, A. Zago, M. Arsand, 2004, Clinical genetics.

Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes

M. Hutz, L. Sand, M. Fiegenbaum, 2005, The Pharmacogenomics Journal.

The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid‐lowering efficacy and safety of simvastatin treatment

M. Hutz, Marilu Fiegenbaum, Fabiano R. Silveira, 2005, Clinical pharmacology and therapeutics.